🔬

FOXO4-DRI

FOXO4-p53 · Senolytic peptide

Preclinical📈 TrendingExperimental Research

Engineered D-retro-inverso peptide that selectively induces apoptosis in senescent cells, reversing aging hallmarks in mice.

Half-Life

~4–6 hours (DRI form is more stable than L-form)

N/A

Amino Acids

N/A

Evidence

Preclinical

Add to Protocol

Regulatory Status

Research compound only

How it works: Add BAC water to your vial → calculator finds concentration → divides your dose by concentration → shows units to draw on a standard 100-unit insulin syringe. Values are pre-filled from research reference defaults — adjust to match your actual vial.

Vial Size (mg)

BAC Water (mL)

Dose (mcg)

fill level

Draw

units on a 100-unit syringe

= 0.3 mL

Conc.

5000

mcg/mL

Vol/dose

0.3

Doses/vial

inj.

Research reference values only. Confirm all parameters with current literature and your clinician.

Looking for multi-compound protocols?

Browse educational protocol discussions that include FOXO4-DRI.

Protocol Library

Related Compounds

Humanin

A mitochondria-derived peptide encoded in the 16S rRNA region with remarkable cytoprotective, anti-apoptotic, and longevity-associated properties.

SS-31

A cardiolipin-targeted mitochondria-protective peptide showing remarkable results in heart failure, AMD, and mitochondrial disease research.

MOTS-c

A mitochondrial-derived peptide that regulates metabolic homeostasis, glucose uptake, and has shown remarkable longevity effects in animal studies.

Educational Disclaimer: All information on this page is for educational and research purposes only. This does not constitute medical advice, diagnosis, or treatment recommendation. Consult a qualified healthcare professional.